Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$10,616,882
in 14 filings, $3.0M under 10b5-1 plans

Net −$10,616,882. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 97 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-20 JOHNSON DAVID EDWARD Director Grant or award +20,359 20,359
2024-06-20 Horobin Joanna Director Grant or award +20,359 20,359
2024-06-20 deGoa Damian Director Grant or award +20,359 68,075
2024-06-20 Bloch Stephen M Director Grant or award +20,359 20,359
2024-06-03 Kaseta Michael CFO and COO Sale 10b5-1 −1,094 $14.55 $16K 316,295
2024-06-03 Adair Jason Chief Business Officer Sale 10b5-1 −455 $14.55 $7K 112,465
2024-06-03 Schundler Russell General Counsel Sale 10b5-1 −710 $14.55 $10K 487,661
2024-06-03 Moomaw Scott Chief Commercial Officer Sale 10b5-1 −546 $14.55 $8K 153,210
2024-05-31 Kaseta Michael CFO and COO Exercise or conversion 10b5-1 +2,344 317,389
2024-05-31 Kaseta Michael CFO and COO Exercise or conversion · Restricted Stock Unit 10b5-1 −2,344 16,406
2024-05-31 Adair Jason Chief Business Officer Exercise or conversion 10b5-1 +1,563 112,920
2024-05-31 Adair Jason Chief Business Officer Exercise or conversion · Restricted Stock Unit 10b5-1 −1,563 10,937
2024-05-31 Schundler Russell General Counsel Exercise or conversion 10b5-1 +2,344 488,371
2024-05-31 Schundler Russell General Counsel Exercise or conversion · Restricted Stock Unit 10b5-1 −2,344 16,406
2024-05-31 Moomaw Scott Chief Commercial Officer Exercise or conversion 10b5-1 +1,875 153,756
2024-05-31 Moomaw Scott Chief Commercial Officer Exercise or conversion · Restricted Stock Unit 10b5-1 −1,875 13,125
2024-04-19 Saggar Rajeev Chief Medical Officer Sale 10b5-1 −1,649 $13.68 $23K 211,672
2024-04-12 Schundler Russell General Counsel Sale 10b5-1 −2,060 $14.58 $30K 486,027
2024-04-12 Saggar Rajeev Chief Medical Officer Sale 10b5-1 −1,525 $14.58 $22K 213,321
2024-04-12 Moomaw Scott Chief Commercial Officer Sale 10b5-1 −1,585 $14.58 $23K 151,881

Page 32 of 39 · 771 trades